Teva Pharmaceutical Industries Newsroom

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsSep 24 06:32 ET

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsSep 24 03:32 ET

Jefferies Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsSep 23 08:33 ET

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Announces Target Price $22

Moomoo NewsSep 19 10:31 ET

Jefferies Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsSep 9 08:33 ET

UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsSep 9 04:31 ET

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6 08:42 ET

UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $26

Moomoo NewsSep 3 10:31 ET

Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $23

Moomoo NewsAug 28 08:33 ET

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating

Moomoo NewsAug 22 11:31 ET

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsAug 5 04:32 ET

Argus Research Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating

Moomoo NewsAug 2 11:31 ET

Evercore Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating

Moomoo NewsAug 2 08:31 ET

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $22

Moomoo NewsAug 2 04:33 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaAug 1 12:52 ET

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsAug 1 06:37 ET

Barclays Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)

TipRanksJul 30 03:58 ET

Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsJul 24 07:33 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJul 10 22:12 ET

Argus Upgrades Teva to Buy, Cites Recent Drug Approvals

Seeking AlphaJul 10 13:19 ET